Cargando…

Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma

BACKGROUND: We aimed to explore long-term predictors of severe exacerbations and mortality in adults with well-characterised asthma. STUDY DESIGN AND METHODS: Adults (aged ≥ 15) with an objectively verified diagnosis of asthma were recruited from a Danish respiratory outpatient clinic between 1974 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tupper, Oliver Djurhuus, Ulrik, Charlotte Suppli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529759/
https://www.ncbi.nlm.nih.gov/pubmed/34670588
http://dx.doi.org/10.1186/s12931-021-01864-z
_version_ 1784586534411829248
author Tupper, Oliver Djurhuus
Ulrik, Charlotte Suppli
author_facet Tupper, Oliver Djurhuus
Ulrik, Charlotte Suppli
author_sort Tupper, Oliver Djurhuus
collection PubMed
description BACKGROUND: We aimed to explore long-term predictors of severe exacerbations and mortality in adults with well-characterised asthma. STUDY DESIGN AND METHODS: Adults (aged ≥ 15) with an objectively verified diagnosis of asthma were recruited from a Danish respiratory outpatient clinic between 1974 and 1990. All individuals were followed in Danish registries for vital status, hospital admissions for asthma and cause of death until end of 2017. Predictors of exacerbations were obtained from a repeated measures model. Standardised mortality rates (SMR) for all-causes were compared with the Danish background population. Hazard ratios for mortality were obtained from a cox proportional hazards model in a two-step process. RESULTS: At baseline, the cohort comprised 1071 patients (mean age 38, SD 16, 61% women), of whom 357 (33%) died during follow-up, with 93 (26%) dying from asthma (primary diagnosis). We found an SMR of 1.24 (95% CI 1.11–1.37, p < 0.001) for all-cause mortality. Baseline predictors for asthma-related death and repeated severe exacerbations were increasing age, ever smoker, FEV(1) < 80% pred., high blood eosinophils, longer duration of symptoms and use of SABA > twice daily. Being non-atopic, having a positive histamine challenge test and symptoms more than twice a week were also predictors of repeated exacerbations. CONCLUSIONS: Markers of poor asthma control, including high use of SABA, are predictors of long-term exacerbation rate and mortality over 30 years in patients with well-characterised asthma. Improving asthma control, including lung function and reducing use of reliever medication, is vital for improving the long-term outcome of asthma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-021-01864-z.
format Online
Article
Text
id pubmed-8529759
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85297592021-10-25 Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma Tupper, Oliver Djurhuus Ulrik, Charlotte Suppli Respir Res Research BACKGROUND: We aimed to explore long-term predictors of severe exacerbations and mortality in adults with well-characterised asthma. STUDY DESIGN AND METHODS: Adults (aged ≥ 15) with an objectively verified diagnosis of asthma were recruited from a Danish respiratory outpatient clinic between 1974 and 1990. All individuals were followed in Danish registries for vital status, hospital admissions for asthma and cause of death until end of 2017. Predictors of exacerbations were obtained from a repeated measures model. Standardised mortality rates (SMR) for all-causes were compared with the Danish background population. Hazard ratios for mortality were obtained from a cox proportional hazards model in a two-step process. RESULTS: At baseline, the cohort comprised 1071 patients (mean age 38, SD 16, 61% women), of whom 357 (33%) died during follow-up, with 93 (26%) dying from asthma (primary diagnosis). We found an SMR of 1.24 (95% CI 1.11–1.37, p < 0.001) for all-cause mortality. Baseline predictors for asthma-related death and repeated severe exacerbations were increasing age, ever smoker, FEV(1) < 80% pred., high blood eosinophils, longer duration of symptoms and use of SABA > twice daily. Being non-atopic, having a positive histamine challenge test and symptoms more than twice a week were also predictors of repeated exacerbations. CONCLUSIONS: Markers of poor asthma control, including high use of SABA, are predictors of long-term exacerbation rate and mortality over 30 years in patients with well-characterised asthma. Improving asthma control, including lung function and reducing use of reliever medication, is vital for improving the long-term outcome of asthma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-021-01864-z. BioMed Central 2021-10-20 2021 /pmc/articles/PMC8529759/ /pubmed/34670588 http://dx.doi.org/10.1186/s12931-021-01864-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tupper, Oliver Djurhuus
Ulrik, Charlotte Suppli
Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
title Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
title_full Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
title_fullStr Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
title_full_unstemmed Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
title_short Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
title_sort long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529759/
https://www.ncbi.nlm.nih.gov/pubmed/34670588
http://dx.doi.org/10.1186/s12931-021-01864-z
work_keys_str_mv AT tupperoliverdjurhuus longtermpredictorsofsevereexacerbationsandmortalityinacohortofwellcharacterisedadultswithasthma
AT ulrikcharlottesuppli longtermpredictorsofsevereexacerbationsandmortalityinacohortofwellcharacterisedadultswithasthma